诺泰生物大幅上涨青海省医保局调整检验类项目价格

智选洞察11-11

11月11日，诺泰生物（688076）股价大幅上涨，截至13点10分，诺泰生物上涨5.02%，报55.20元/股，成交4.16亿元，换手率3.53%。消息解读青海省医保局发布公告，将血栓弹力图实验、糖化血红蛋白(HbA1c)测定、B型钠尿肽(BNP)测定及N端-B型钠尿肽前体 (NT-ProBNP)测定等四项检查检验类项目的价格进行调整，平均降幅达到50%以上。此举不仅标志着医保管理者在价格调控上...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2482226841?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-11 13:10","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2482226841","market":"sh","top_or_hot":-1,"title":"诺泰生物大幅上涨 青海省医保局调整检验类项目价格","media":"智选洞察","content":"<div>\n<p>11月11日，诺泰生物（688076）股价大幅上涨，截至13点10分，诺泰生物上涨5.02%，报55.20元/股，成交4.16亿元，换手率3.53%。消息解读青海省医保局发布公告，将血栓弹力图实验、糖化血红蛋白(HbA1c)测定、B型钠尿肽(BNP)测定及N端-B型钠尿肽前体 (NT-ProBNP)测定等四项检查检验类项目的价格进行调整，平均降幅达到50%以上。此举不仅标志着医保管理者在价格调控上...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111131109abb4bfa2&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>诺泰生物大幅上涨 青海省医保局调整检验类项目价格</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n诺泰生物大幅上涨 青海省医保局调整检验类项目价格\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-11 13:10 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111131109abb4bfa2&s=b><strong>智选洞察</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>11月11日，诺泰生物（688076）股价大幅上涨，截至13点10分，诺泰生物上涨5.02%，报55.20元/股，成交4.16亿元，换手率3.53%。消息解读青海省医保局发布公告，将血栓弹力图实验、糖化血红蛋白(HbA1c)测定、B型钠尿肽(BNP)测定及N端-B型钠尿肽前体 (NT-ProBNP)测定等四项检查检验类项目的价格进行调整，平均降幅达到50%以上。此举不仅标志着医保管理者在价格调控上...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111131109abb4bfa2&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688076","symbol_name":"诺泰生物","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111131109abb4bfa2&s=b","article_id":"2482226841","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111131109abb4bfa2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2482226841","pubTimestamp":1731301817,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"11月11日，诺泰生物股价大幅上涨，截至13点10分，诺泰生物上涨5.02%，报55.20元/股，成交4.16亿元，换手率3.53%。资金动向截止发稿，诺泰生物获得主力净流入1450万元，其中超大单流入1391万元，大单流入58万元。主营业务及业绩诺泰生物公司主营业务为多肽药物及小分子化药进行自主研发与定制研发生产。最新财报显示，今年三季报，诺泰生物实现营业收入12.52亿元，同比增长76.51%，净利润为3.50亿元，同比增长281.90%，基本每股收益为1.62元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688076":"诺泰生物","BK0239":"医药制造"},"translate_title":"Nuotai Biotech rises sharply, Qinghai Provincial Medical Insurance Bureau adjusts the price of inspection items","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688076":1},"content_text":"11月11日，诺泰生物（688076）股价大幅上涨，截至13点10分，诺泰生物上涨5.02%，报55.20元/股，成交4.16亿元，换手率3.53%。消息解读青海省医保局发布公告，将血栓弹力图实验、糖化血红蛋白(HbA1c)测定、B型钠尿肽(BNP)测定及N端-B型钠尿肽前体 (NT-ProBNP)测定等四项检查检验类项目的价格进行调整，平均降幅达到50%以上。此举不仅标志着医保管理者在价格调控上的审慎与深思，也折射出医疗保障政策在价格调节、资源分配和健康公平性方面的权衡。河南省医保局印发《关于开展医疗服务价格规范治理(第一批)的通知》(豫医保办〔2024〕74号)(以下简称《通知》)，降低“血栓弹力图试验(TEG)”等5个检验项目价格。此次价格调整是落实国家医保局统一部署的医疗服务价格规范治理工作，重点对部分地区间价格差异大、成本构成悬殊的检验项目进行规范治理，推进地区间医疗服务价格水平相对均衡，维护人民群众的合法权益。此外，数据统计显示，近半年内3家券商给予增持建议，25家券商给予买入建议。资金动向截止发稿，诺泰生物获得主力净流入1450万元，其中超大单流入1391万元，大单流入58万元。数据显示，该股今日净流入较近5日净流入均值增加796万元。融资融券方面，诺泰生物11月08日获得融资净买入61万元，当日该股融资余额为3.68亿元，当较前一日增加0.17%；该股融券余额为57万元，融券余量为1.05万股，比上日增加5.00%。主营业务及业绩诺泰生物公司主营业务为多肽药物及小分子化药进行自主研发与定制研发生产。最新财报显示，今年三季报，诺泰生物实现营业收入12.52亿元，同比增长76.51%，净利润为3.50亿元，同比增长281.90%，基本每股收益为1.62元。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2482226841"}

诺泰生物大幅上涨 青海省医保局调整检验类项目价格

精彩评论

诺泰生物大幅上涨青海省医保局调整检验类项目价格